19 Sep, EOD - Indian

Nifty Pharma 22686.6 (0.50)

Nifty Bank 55458.85 (-0.48)

Nifty 50 25327.05 (-0.38)

SENSEX 82626.23 (-0.47)

Nifty IT 36578.25 (-0.47)

Nifty Smallcap 100 18504.55 (0.15)

Nifty Next 50 69736.6 (0.58)

Nifty Midcap 100 59094.35 (0.04)

19 Sep, EOD - Global

NIKKEI 225 45045.81 (-0.57)

HANG SENG 26545.1 (0.00)

S&P 6734.5 (0.43)


Corporate News

You are Here : Home > News > Corporate News >

(16 Sep 2025, 08:29)

Stock Alert: Adani Enterprises, Tega Industries, NCC, Transrail Lighting


Securities in F&O Ban:

RBL Bank, HFCL, Angel One and Oracle Financial Services Software shares are banned from F&O trading on 16 September 2025.

Stocks to Watch:

Adani Enterprises has received a letter of award (LoA) from National Highways Logistics Management for building the prestigious ropeway project connecting Sonprayag with Kedarnath. The company will invest Rs 4,081 crore in its first ropeway project between Sonprayag and Kedarnath.

Tega Industries has announced that its board will meet on 18 September 2025 to consider a proposal to raise funds through equity.

NCC announced that it has received an order worth Rs 2,090.5 crore from the Bihar Water Resources Department for the construction of the Barnar reservoir, dam structures, irrigation channels, and other associated works.

Transrail Lighting announced that it has received an order worth Rs 421 crore in Africa. With this, the company’s order inflows for the current fiscal year have crossed the Rs 3,500 crore mark as of August 2025.

Sanghvi Movers’ arm has received orders worth Rs 292 crore for construction work from independent power producers.

John Cockerill India has received an order worth Rs 80 crore from Tata Steel for the manufacturing and supply of critical components required for the push-pull pickling line and acid regeneration plants. The company will also supervise the erection and commissioning of the plants to meet the contractual performance guarantee. Additionally, John Cockerill has appointed Ujwal Kawale as Chief Operating Officer.

Zydus Lifesciences announced that its arm has launched the first generic drug for canine urinary incontinence, along with furosemide tablets, a critical therapy for managing congestive heart failure and chronic fluid retention in dogs and cats.

More News

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +